Seasonal influenza VLP vaccine: Phase IIa completed

Novavax completed enrollment of about 300 healthy volunteers in a double-blind, placebo-controlled, U.S. Phase lla trial evaluating a single IM injection of 5, 15 or 30 µg of the Seasonal influenza VL...